Ubs Asset Management Americas Inc Jazz Pharmaceuticals PLC Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 274,051 shares of JAZZ stock, worth $37.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
274,051
Previous 197,174
38.99%
Holding current value
$37.7 Million
Previous $24.5 Million
18.8%
% of portfolio
0.01%
Previous 0.01%
Shares
31 transactions
Others Institutions Holding JAZZ
# of Institutions
561Shares Held
62.7MCall Options Held
563KPut Options Held
77.8K-
Black Rock Inc. New York, NY6.15MShares$846 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$838 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.55MShares$351 Million0.65% of portfolio
-
Capital World Investors Los Angeles, CA2.54MShares$350 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$349 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.62B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...